Literature DB >> 6769823

Immunogenicity of ribosomal preparations from Neisseria gonorrhoeae.

M D Cooper, R P Tewari, D V Bowser.   

Abstract

Protection against gonococcal infection was obtained by immunization with ribosomal preparations from Neisseria gonorrhoeae. Ribosomes were isolated from disrupted cells by differential ultracentrifugation and treatment of the microsomal fraction with 0.25% sodium dodecyl sulfate. The isolated ribosomal preparations contained 55% ribonucleic acid, 39% protein, and 0.35% carbohydrate. The ribosomal preparations contained small amounts of endotoxin as determined by thiobarbituric acid- and lead acetate-sensitized mice assays. Guinea pigs immunized subcutaneously with ribosomal preparations were challenged intrachamberially with 10(7) colony-forming units of N. gonorrhoeae, and protection was assessed by clearance of the organism from subcutaneous chambers. The ribosomal preparations elicited significant protection, which was enhanced by incoporation of the immunogen into adjuvant. This protection was comparable to that obtained with whole cells. Treatment with proteolytic enzymes destroyed the protective effect of the ribosomal preparations, but ribonuclease had no measurable effect. Passive hemagglutination and immunodiffusion tests with sera from immunized animals demonstrated the presence of antibody to the ribosomal antigens. Results of adsorption of antiribosomal sera with enzyme-treated ribosomal preparations also indicated the protein nature of the immunogen. These results indicate that protein associated with the gonococcal ribosomal preparation is the major protective immunogen. The role of endotoxin contamination in the immunogenicity of gonococcal ribosomal preparations warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6769823      PMCID: PMC550897          DOI: 10.1128/iai.28.1.92-100.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  STUDIES ON THE GRAM-NEGATIVE CELL WALL. I. EVIDENCE FOR THE ROLE OF 2-KETO- 3-DEOXYOCTONATE IN THE LIPOPOLYSACCHARIDE OF SALMONELLA TYPHIMURIUM.

Authors:  M J OSBORN
Journal:  Proc Natl Acad Sci U S A       Date:  1963-09       Impact factor: 11.205

2.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

3.  Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium.

Authors:  P Hoops; N E Prather; J Berry; J M Ravel
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

4.  Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction.

Authors:  C L Swendsen; W Johnson
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

5.  Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella.

Authors:  T K Eisenstein
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

6.  Biochemical and immunological properties of ribonucleic acid-rich extracts from Francisella tularensis.

Authors:  I I Andron LA; H T Eigelsbach
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

7.  The lipopolysaccharides of Neisseria gonorrhoeae colony types 1 and 4.

Authors:  M B Perry; V Daoust
Journal:  Can J Biochem       Date:  1975-05

8.  Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity.

Authors:  M M Lieberman
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

9.  Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.

Authors:  M R Venneman; N J Bigley
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

10.  Comparative efficacy and toxicity of a ribosomal vaccine, acetone-killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhhimurium.

Authors:  C R Angerman; T K Eisenstein
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

View more
  8 in total

1.  Analysis of immune responses in genital tracts of mice immunised with purified ribosomal fractions of Neisseria gonorrhoeae.

Authors:  E Kita; S Kashiba
Journal:  Br J Vener Dis       Date:  1984-08

2.  In vitro kinetics of phagocytosis and intracellular killing of gonococci by peritoneal macrophages from mice deficient in complement component 5.

Authors:  M D Cooper; S A Floyd
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

3.  Characterization of the immune response in subcutaneous chambers of guinea pigs immunized with a ribosomal preparation from Neisseria gonorrhoeae.

Authors:  M J Wannemuehler; R D Miller; M D Cooper
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

4.  Detection of antibodies against Candida albicans ribosomes by the enzyme linked immunosorbent assay.

Authors:  R Levy; E Segal; E Eylan
Journal:  Mycopathologia       Date:  1984-09-30       Impact factor: 2.574

5.  Role of outer envelope contamination in protection elicited by ribosomal preparations against Neisseria gonorrhoeae infection.

Authors:  M D Cooper; M J Wannemuehler; R D Miller; M F Fedyk
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

6.  Recombinant L7/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells.

Authors:  S C Oliveira; Y Zhu; G A Splitter
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

7.  Ribonuclease-sensitive ribosomal vaccines.

Authors:  R Gonggrijp; A C Antonissen; J F van den Bosch; C P van Boven
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

8.  Opsonization and phagocytosis of Haemophilus influenzae type B organisms by mouse polymorphonuclear leucocytes and antiribosomal serum.

Authors:  M A Katz; M Solotorovsky; M Lynn
Journal:  Br J Exp Pathol       Date:  1983-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.